100m Russia Covid doses for India

 

The Telegraph India,   |   New Delhi   | 

G.S. Mudur  

 17.09.20, 02:11 AM

“The phase 1 and phase 2 results have shown promise. We will be conducting phase 3 trials in India to meet the requirements of Indian regulators,” DRL managing director G.V. Prasad said in the statement.

Vaccine researchers say a clinical trial in India, if approved by the regulatory authority, would likely involve a few thousand healthy volunteers. The proposal to distribute 100 million doses is intended to support a mass vaccination campaign, the researchers said.

“They are meant for population-wide general use — a mass vaccination campaign,” a spokesperson for the RDIF told The Telegraph, adding that an application for the clinical trials in India would be filed soon.

The application will need to be filed with the Central Drugs Standard Control Organisation (CDSCO), India’s regulatory authority for drugs and vaccines. Under standard procedures, any mass vaccination can only start after the results of phase 3 trials have been assessed as successful.

However, the CDSCO can under certain exceptional circumstances approve “emergency authorisation” use for either a drug or a vaccine ahead of standard trial requirements.

India’s health minister Harsh Vardhan had on Sunday hinted that the Centre might consider emergency authorisation of Covid-19 vaccination “especially in the case of senior citizens and people working in high-risk settings”.

Senior health officials had said earlier this week that the CDSCO had not yet received any proposal for emergency authorisation of a Covid-19 vaccine.

“We believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against Covid-19,” Kirill Dmitriev, RDIF’s CEO, said.

Russia is also looking to use India as a source of mass production of the vaccine for which the RDIF is in talks with several vaccine makers, a spokesperson said.

The Russian agency said over 55,000 volunteers had applied to take part in post-registration trials. The first results of these trials are expected to be published in October or November.

“The data in their scientific paper look impressive,” said Sudanshu Vrati, a senior virologist and director of the Regional Centre for Biotechnology, Faridabad (Haryana).

“But the actual proof of protection from the infection will only come from phase 3 trials.”

The phase 1 trials primarily assess the safety of the vaccine while phase 2 trials are intended to find out whether a candidate vaccine will generate an immune response in the recipients. In the phase 3 trial, the candidate will be assessed for its capacity to protect the recipients from future infection.

India is also independently assessing two home-grown vaccines, currently in phase 2 trials, and an Oxford-made vaccine in phase 3 trials.

Reference: https://www.telegraphindia.com/india/coronavirus-outbreak-100m-russia-vaccine-doses-for-india/cid/1792205

Comments

Post a Comment

Popular posts from this blog

India Joins Russia in Voting Against West-Backed Move to Expand Powers of OPCW

The Wire: June 28, 2018 New Delhi: India voted against a UK-backed move that will allow the global chemical weapons watchdog to apportion blame for illegal attacks, criticising the decision to grant “unchecked powers” to the head of the group which could be used for “partisan” purposes. On Wednesday, more than two-thirds of the member states of the Organisation for the Prohibition of Chemical Weapons (OPCW) voted to authorise the international body to identify the perpetrators and sponsors of a chemical weapons attack. It also specifically called on the OPCW’s technical secretariat to begin work on identifying the perpetrators behind the use of chemical weapons in Syria. The draft decision, sponsored by 30 countries, was adopted at the fourth special session of the conference of the states parties to the Chemical Weapons Convention at the Hague, with 82 in favour and 24 negative votes. While Europe, the United States and their allies voted ‘yes’, there was strong oppo...
Read more

As financial insecurity rises in urban India, so does investment in insurance

Image
Scroll.in March 13, 2020 Urban Indians are becoming less confident about their financial security. Up to 58% of them fret over financial independence post retirement, which is a 4% increase from last year. An equal share of urban Indians worry about meeting their daily medical expenses and sustaining their current lifestyle once they stop working. The findings are part of a survey published by Delhi-based Max Life Insurance in association with London-based consultancy Kantar. The firms surveyed 7,014 respondents in 25 cities, including six metros, nine tier-1 cities, and 10 tier-2 cities, between December 2019 and January 2020. Source: Max Life Insurance via Quartz The trends Source: Max Life Insurance via Quartz Source: Max Life Insurance via Quartz Source: Max Life Insurance via Quartz A significant share of urban Indians also say their families will have no financial support in the event of the breadwinner’s death. In such a scenario, around 57% believe the family sav...
Read more

ED tracks Swiss Bank A/Cs of Agusta scamster

The Poineer February 10,2019 Rakesh K Singh The Enforcement Directorate (ED) has tracked a dozen Swiss bank accounts in the name of Rajiv Saxena, who is key accused in the Rs 3,600 crore AgustaWestland VVIP chopper scam. The ED has also found out accounts held by  his family members and associates where the kickbacks in the now scrapped deal were allegedly parked. Two bank accounts are in the name of Rajiv Saxena’s  associates Pankaj Jain and Sumita Jain who are also the authorised signatories. The  third is in the name of another associate Ajit Singh Bubber, but Rajiv and his family members are authorised signatories. The remaining nine accounts are largely owned and operated by Rajiv, his family members and associates. Rajiv Saxena was deported by the UAE authorities on January 30 and the ED formally arrested him the next day and a court later granted his remand to the agency. He is currently undergoing custodial interrogation by the ED. The agency had in 2017...
Read more